Hu, Huanrong <br/><br/>
Antibiotic drug tigecycline inhibits melanoma progression and metastasis in a p21CIP1/Waf1-dependent manner.  [electronic resource] 

 -  Oncotarget  Jan 2016 
 - 3171-85 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.6419  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Cyclin E--biosynthesis<br/>Cyclin-Dependent Kinase 2--biosynthesis<br/>Cyclin-Dependent Kinase Inhibitor p21--metabolism<br/>Disease Progression<br/>Down-Regulation--drug effects<br/>Epithelial-Mesenchymal Transition--drug effects<br/>Female<br/>G1 Phase Cell Cycle Checkpoints--drug effects<br/>Humans<br/>Melanoma--drug therapy<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Minocycline--analogs & derivatives<br/>Neoplasm Invasiveness--prevention & control<br/>Neoplasm Metastasis--drug therapy<br/>Oncogene Proteins--biosynthesis<br/>Skin Neoplasms<br/>Tigecycline<br/>Xenograft Model Antitumor Assays<br/>Melanoma, Cutaneous Malignant